Market Research Blog – Page 3181 – New Product Development

Global Nerve Repair Industry is expected to grow at an astounding 12.2% CAGR and reach US$ 861.4 Million by 2033 | FMI

The Global Nerve Repair Industry is on track for a remarkable surge, with projections indicating a staggering 12.2% Compound Annual Growth Rate (CAGR) over the next decade. By 2033, the market is expected to reach a value of US$861.4 million, significantly surpassing the impressive US$272.4 million projected for the end of 2023.

This phenomenal growth is primarily driven by the increasing prevalence of neurological disorders such as Alzheimer’s and Parkinson’s disease. As these conditions become more widespread, the need for innovative and effective nerve repair solutions becomes ever more critical.

Furthermore, the market’s expansion is gaining momentum due to the continuous advancements in neurological treatments. This progress is exemplified by the recent developments in the industry, such as Medtronic’s groundbreaking achievements in 2022. Medtronic received approval from the United States Food and Drug Administration (FDA) for its Intellis neurostimulator and Vanta neurostimulator, both designed to treat chronic pain associated with diabetic peripheral neuropathy (DPN). These innovations signify a significant leap forward in the field of nerve repair and treatment.

Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-2680

The prevalence of various chronic nervous system diseases, including Parkinson’s and Alzheimer’s, is expected to increase throughout the projection period, which is also expected to drive up demand for treatments that heal damaged nerves. Also, it is anticipated that market expansion may quicken as a result of scientific developments in neurological therapies. Recent research indicates that there has been a sharp increase in incidences of nerve damage in industrialized nations, which has fueled the market’s demand. According to the American Association for Peripheral Nerves, 1.2 million treatments are carried out annually in the United States alone.

Global Nerve Repair Industry Key Takeaways:

Prominent market players in the Global Nerve Repair Industry are keeping an eye on the East and South Asia markets to capitalize on the growing demand for neurological products combined with rising awareness in countries including India, China, and Japan. The key players are also tapping into the markets of Mexico, Indonesia, and other Middle Eastern nations. This is also expected to fuel the demand in the nerve repair market.
In addition, prominent producers in the market are investing heavily in streamlining their R&D and improving production for nerve repair products. Owing to the cost-effectiveness achieved by outsourcing their manufacturing capabilities, CDMOs will likely anticipate a profitable decade.
When there is a damaged nerve, it can lead to serious motor and sensory issues that are expected to ache and cause the appendages to malfunction. Therefore, health professionals employing biomaterials in the nerve repair process are included in products for nerve repair. The autograft is the gold standard for nerve repair procedures, although the specifics of the procedure are determined by the type and severity of the nerve injury.
Technologically advanced nerve repair therapies are utilized to efficiently treat damage brought on by trauma and several other factors, which is known as a key factor responsible for influencing the market. Adult stem cells can easily be extracted from adipose tissue, skin, and bone marrow, and are now being employed in many developed nations to repair and regenerate nerves.
Key players in the market are rising the manufacturing of nerve repair products as the prevalence of neurological disorders across the globe. Moreover, an increase in nerve repair expenditure is likely to drive sales in the nerve repair market over the forecast period (2022-2032).
An estimation of US$ 150 billion is predicted to have been spent on medical care for nerve injuries annually in the U.S. This showcases the expenditure on nerve repair, replacement, and regeneration due to a rise in cases of indications like amyotrophic lateral sclerosis, multiple system atrophy, Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis.

Ask An Analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-2680

Competitive Landscape:

With the establishment of several key nerve repair production companies all over the world, the overall market is anticipated to be highly fragmented. Key players are increasing R&D efforts to expand their novel product portfolios to maintain a strong foothold over the entire industry. Various products are still in the pipeline stage as the companies are proceeding toward promoting regularization and licensing of these pipelined products after assessing their efficacy.

More Insights into the Global Nerve Repair Industry

The U.S. held approximately 89.5% share in the Global Nerve Repair Industry in 2021, opines FMI. Sales in the U.S. are slated to grow at an impressive CAGR of 13.3% during the forecast period.

Global Nerve Repair Industry Key Companies Profiled

Axogen Inc.
Stryker Corporation
Baxter International Inc.
Integra Lifesciences Holdings Corp
Neurotex Ltd
Polyganics B.V.
Abbott Laboratories
Boston Scientific Inc
Medtronic Plc
Checkpoint Surgical
Polyganics
Synovis Micro Companies Alliance
Orthomed, Inc

Get Your Customized Impactful Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-2680

Key Segments Covered in Global Nerve Repair Industry Research

By Product:

Nerve Wrap
Nerve Protector
Nerve Connector
Nerve Graft

By Nerve Repair:

Epineural Nerve Repair
Perineural Nerve Repair
Fascicular Nerve Repair

By End User:

Hospitals
Ambulatory Surgical Centers
Specialty Clinics

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
The Middle East and Africa (MEA)

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Respiratory Devices Industry is expected to grow at a robust 8.7% annual rate and reach US$55.9 Billion by 2033. | FMI Report

According to industry experts, the Global Respiratory Devices Industry is poised for a remarkable surge, with a projected market valuation of US$55.9 billion by 2033. This significant increase represents a staggering leap from the anticipated US$24.2 billion in 2023, driven by a robust compound annual growth rate (CAGR) of 8.7% over the next decade.

This phenomenal growth trajectory is fueled by a confluence of critical factors. The market for therapeutic respiratory devices, such as inhalers and nebulizers, has experienced substantial growth in recent years. This surge is primarily driven by the escalating prevalence of respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD) across the globe.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-794

The Therapeutic Global Respiratory Devices Industry is anticipated to reach US$ 50.6 billion in value in 2023. From 2023 to 2033, the market is projected to expand at a CAGR of 4.7%, reaching US$ 80.2 billion.

The product landscape of the therapeutic Global Respiratory Devices Industry encompasses a wide range of devices, including inhalers, nebulizers, ventilators, continuous positive airway pressure (CPAP) machines, and oxygen concentrators. These devices are utilized in various settings, including hospitals, clinics, home care, and ambulatory care centers.

As governments and healthcare organizations across the globe strive to improve healthcare infrastructure, access to medical facilities, and patient outcomes, the demand for therapeutic respiratory devices is expected to continue rising. Additionally, the COVID-19 pandemic has highlighted the importance of respiratory support devices, resulting in increased investments in research and development to introduce more advanced and effective solutions.

Global Respiratory Devices Industry Key Takeaways:

Existence of modern healthcare facilities in the United States and Canada, the?therapeutic respiratory devices market?in North America gained over 36% market share in 2021.
The Asia Pacific is predicted to expand the quickest throughout the forecast period, owing to factors such as increased asthma incidence in adults and children, as well as technology improvements.
Additionally, the market expansion would be aided by rising healthcare awareness and improved healthcare infrastructure.
The clinical trial of Tempol for the treatment of COVID-19 by?Adams Respiratory Therapeutics Inc?has surpassed enrollment expectations.
COPD is estimated to affect 10% of adults aged 75 and older in the United States, according to the Journal of the Italian Society of Gerontology and Geriatrics.
According to statistics issued by the Global Initiative for Asthma (GINA), an estimated 100 million people with asthma are expected to be diagnosed by 2025.

Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-794

Competitive Landscape:

Carefusion Corporation, G.E. Healthcare, Chart industries, Philips Healthcare, Compumedics Ltd., Smiths Medical, Covidien PLC, Invacare, Fisher and Paykel, and Mindray are some of the major?respiratory device companies.

Acquisitions and mergers, the launch of new products and services, partnerships and joint ventures, MoU agreements, V.C. and funding activities, R&D activities, and geographic expansion, among other noteworthy activities by key players in the therapeutic Global Respiratory Devices Industry, are among the key strategic developments in the competitive landscape.

Acapella, a select blue vibratory PAP therapy device, was released by Smiths Medical in April 2021. It is a drug-free supplementary therapy for people with asthma, COPD, cystic fibrosis, and lung illness that aids in the evacuation of secretions.
Koninklijke Philips N.V. finalized the acquisition of BioTelemetry, Inc., a firm located in the United States, in February 2021. This aided in the expansion of Philips’ product line, resulting in increased sales of therapeutic respiratory devices.

Key Segments from the Global Respiratory Devices Industry:

By Product:

Positive Airway Pressure (PAP) Devices
- Continuous Positive Airway Pressure (CPAP) Devices
- Auto-titrating Positive Airway Pressure (APAP) Devices
- Bi-level Positive Airway Pressure (BiPAP) Devices
Oxygen Concentrator
- Fixed Oxygen Concentrators
- Portable Oxygen Concentrators
Ventilators
- Adult Ventilators
- Neonatal Ventilators
Inhalers
- Metered Dose Inhaler (MDI)
- Dry Powder Inhaler (DPI)
- Soft Mist Inhaler (SMI)
Nebulizers
- Compressor-based Nebulizers
- Piston-based Hand-held Nebulizers
- Ultrasonic Nebulizers
Humidifiers
- Heated Humidifiers
- Passover Humidifiers
- Integrated Humidifiers
- Built-in Humidifiers
- Standalone Humidifiers
Others

By Application:

COPD
Obstructive Sleep Apnea
Asthma
Respiratory Distress Syndrome
Cystic Fibrosis
Others

By End-use:

Hospital
Homecare Settings
Emergency Centres

Click Here To Buy Your Detailed Report
https://www.futuremarketinsights.com/checkout/794

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Global Compression Garments and Stockings Industry Poised for Steady Growth at 4.9% CAGR, Reaching US$3.9 Billion by 2029 | Says FMI

Global Compression Garments and Stockings Market

The Global Compression Garments and Stockings Industry is on track for significant expansion, driven by a growing emphasis on patient safety, comfort, and rising recommendations from healthcare professionals, according to a recent analysis by Future Market Insights (FMI). The market is projected to register a Compound Annual Growth Rate (CAGR) of 4.9% during the forecast period (2022-2029), reaching an estimated value of US$3.9 billion by 2029. This surge represents a significant increase from the US$2.8 billion valuation recorded in 2022.

A key contributor to this growth is the steady stream of new product launches focused on enhanced patient safety and improved comfort. Manufacturers are continuously innovating to create compression garments and stockings that provide optimal support and therapeutic benefits while ensuring user comfort. This focus on user experience is leading to a rise in product adoption, further propelling market growth.

Request a Sample Copy of the Report Now
https://www.futuremarketinsights.com/reports/sample/rep-gb-3644

Key Takeaways – Compression Garments and Stockings Market Study

The growing adoption of compression garments for orthopedic post-surgical pain management has contributed to the significant market share of the segment by product type.
Hospitals remain as prominent distribution channels for compression garments and stockings for patients suffering from muscle pain, swelling, and bone-related injuries.
Online sales of compression garments and stockings are gathering momentum owing to favorable discounts and free shipping offered by various platforms.
Growing preference for compression garments and stockings among the geriatric population in Western Europe contributed to the significant dominance of the region in the compression garments and stockings industry.
An increasing number of sports injuries and wounds are expected to drive the compression garments and stockings market growth. Strict norms for the use of compression garments and stockings among armed forces personnel and athletes are anticipated to propel the market growth.

Rising Awareness Holds Key to Unlock New Markets

The key manufacturers in the global compression garments and stockings industry are keen to spread awareness about the benefits offered by compression garments and stockings. In May 2017, BSN Medical hosted panel discussions on chronic venous diseases and wound infection management at EWMA 2017. Medi GmbH & Co. KG spreads awareness through its alliance with the German Society for Arthroscopy and Joint Surgery, Eurocom, the German Association for Shoulder and Elbow Surgery, the German Knee Society, and other associations.

Ask the Expert
https://www.futuremarketinsights.com/ask-question/rep-gb-3644

More About Compression Garments and Stockings Market Study

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the segments from 2015 to 2029. The global compression garments and stockings industry is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights into the compression garments and stockings industry based on product type (compression garments, compression stockings), application (varicose vein, wound care, burns, oncology, other indications), and distribution channel (hospitals, ambulatory surgical centers, clinics, online sales, other healthcare facilities) across seven major regions.

Global Compression Garments and Stockings Industry by Category By Product :

Compression Garments
- Upper Compression Garments
- Lower Compression Garments
Compression Stockings
- Anti-Embolism Compression Stockings
- Gradient Compression Stockings

By Application :

Varicose Veins
Wound Care
Burns
Oncology
Others

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/3644

By Distribution Channel :

Hospitals
Ambulatory Surgical Centers
Clinics
Online Sales
Other Healthcare Facilities

By Region :

North America
Western Europe
Eastern Europe
APEX
Japan
Latin America
Middle East and Africa

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

RF Interconnect Market to reach US$ 65.05 billion by 2033, Increasing Adoption of Next-generation Advanced Warfare Systems is Stoking Market Expansion

The RF Interconnect Market is expected to reach US$ 31.56 billion in 2023 and grow at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2033. The market for RF connectivity is expected to be worth US$ 65.05 billion by 2033.

RF (Radio Frequency) interconnects are collections of devices that are connected to each other so that signals may be sent across long distances. These include cables, cable assemblies, attenuators, adapters, and RF connections. The market is expected to rise due to the growing need for RF cable assemblies in the aerospace, military, and telecommunications industries, as well as the growing need for next-generation advanced combat systems.

Request a Sample Copy of the Report https://www.futuremarketinsights.com/reports/sample/rep-gb-16646

Technology Juggernauts Introducing Significant Investments in New Data Centre Infrastructures to Augment their Reach Internationally

In order to expand their worldwide reach, technology companies are focusing on making significant investments in new data center infrastructures, mostly in emerging nations. A large network of connections, such as optical fiber cables and coaxial cables, is needed when setting up new data centers and information and technology (IT) hubs. RF cables should become more popular as a result of this. These results in the escalation of the RF interconnect market trends.

The opening of a new data center region in Spain was made possible by a partnership between Microsoft Corp. and the Spanish telecommunications firm Telefónica S.A. Businesses, both public and private, were the companies’ target markets. To better serve Telefónica S.A.’s consumers globally, they also aimed to strengthen their global strategic partnership and accelerate digital transformation.

Type Category Supremacy Held by the RF Cable Assembly Segment

In the type category, the RF cable assembly segment commanded the RF interconnect market. Cable assembly is the process of assembling one or more cables into a single tube. The ends are given connectors, which are attached to adapters. RF cable assemblies are the cables used to transmit RF signals from one component of a system to another.

Regional Outlook

Through 2033, Asia Pacific is expected to dominate the RF interconnect industry, with a share of 44.02% of all sales. Better manufacturing facilities, better government initiatives, increased construction, and increased expenditures in new infrastructure are some factors that are driving the need for RF interconnect components in the Asia Pacific region.

For instance, the Andaman and Nicobar Islands and the rest of India are now connected by a special underwater optical fiber cable that the Indian Prime Minister inaugurated in August 2020. By enabling quicker internet data transfer, the government hopes to boost the regional economy.

Key Takeaways

With a market value of US$ 9,081.8 million, the market’s dominant segment, RF cable assembly in the type category, is anticipated to record a CAGR of more than 6% during the forecast period.
From 2023 to 2033, the RF cable assembly in the type category grabs RF interconnect market share of around 33%.
During the forecast period, the RF coaxial adapter segment in the type category is anticipated to register a CAGR of around 8.7%.
With a market value of US$ 11,443.0 million and a CAGR of 7.0%, the up to 50 GHz segment of the frequency category dominated.
During the anticipated period, the up to 50 GHz segment of frequency category is expected to gain an RF interconnect market share of 41.9%.
Between 2023 and 2033, the up to 6 GHz sector of frequency category is projected to expand at a CAGR of 8.5%.
With a market share of US$ 19,455.33 million in 2023 and an expected CAGR of 7.4%, the other segment of the end-user category is expected to continue to dominate the market.
Between 2023 and 2033, the industrial sector of the end-user category is projected to expand quickly, with a CAGR of 8.7%.
Between 2023 and 2033, Asia Pacific had a 44.02% revenue share of the global RF interconnect market.
Throughout the projected period, North America is expected to develop at a swift rate, with a CAGR of 8.3%.

Request for Customization https://www.futuremarketinsights.com/customization-available/rep-gb-16646

Competitive Landscape

Quantic Electronics, Delta Electronics, Inc., Cobham Advanced Electronic Solutions, Ducommun Incorporated, and ETL Systems Ltd. are a few well-known RF interconnect market participants.

For industries and sectors such as consumer electronics, networking and communications, automotive, manufacturing, aerospace & military, and healthcare, these businesses manufacture and sell RF interconnects.

The market players are being compelled by changing business models and competitive pressures to shorten development cycles, innovate consistently, miniaturize electronic components, and offer highly reliable and stable RF components.

Recent Development

Acquisition

It was revealed in June 2022 that Quantic Electronics had acquired Microwave Dynamics. Microwave Dynamics created phase-locked and free-running oscillators, frequency multipliers, and converters for use in the industrial, aerospace, and defense sectors. The acquisition increased the portfolio of Quantic Electronics.

Introduction

Amphenol RF added an SMA bulkhead jack to its lineup of RF connectors for demanding environments in December 2022. This IP67-rated waterproof connection can be used to terminate a flexible, low-loss LMR 400 cable. In addition to the features of the well-known interface that are typical of it, this connector provides additional protection against damage to external components.

Request a Report Methodology https://www.futuremarketinsights.com/request-report-methodology/rep-gb-16646

Key Segments

By Type:

RF Cable
RF Cable Assembly
RF Coaxial Adapter
RF Connector

By Frequency:

Up to 6 GHz
Up to 50 GHz
Above 50 GHz

By End User:

Aerospace & Defense
Medical
Industrial
Others

Author:

Sudip Saha is the managing director and co-founder at Future Market Insights, an award-winning market research and consulting firm. Sudip is committed to shaping the market research industry with credible solutions and constantly makes a buzz in the media with his thought leadership. His vast experience in market research and project management a consumer electronics will likely remain the leading end-use sector cross verticals in APAC, EMEA, and the Americas reflects his growth-oriented approach to clients.

He is a strong believer and proponent of innovation-based solutions, emphasizing customized solutions to meet one client’s requirements at a time. His foresightedness and visionary approach recently got him recognized as the ‘Global Icon in Business Consulting’ at the ET Inspiring Leaders Awards 2022.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Medical Carts Industry In North America is expected to grow at a compound annual growth rate of 4.7%, And US$ 3,750.98 Million By 2034 | Future Market Insights Inc

The Medical Carts Industry In North America is poised for a surge, with a projected growth rate of 4.7% by 2034. This remarkable rise, driven by advancements in healthcare and a focus on point-of-care solutions, will see the industry value climb from US$ 2,255.10 million in 2023 to a staggering US$ 3,750.98 million by 2034.

The increasing adoption of EHR systems across North America is a key driver for the growth of the medical carts industry. These mobile workstations provide healthcare professionals with instant access to patient information, enhancing treatment efficiency and accuracy.

The need for streamlining workflow has necessitated the integration of information technology (IT) solutions in healthcare settings. Medical carts manufactured by companies are presently serving the essential purpose of aiding nursing operations in medical facilities. The robust healthcare infrastructure in the US will demand the adoption of advanced medical carts that not only dispense medical instruments & supplies but also have integrated IT systems. In the years to come, the demand for medical carts in North America will witness a steadfast inclination towards IT-integrated medical carts.

Request Sample Copy of this Report:
https://www.futuremarketinsights.com/reports/sample/rep-na-3608

Constructive Prospects for the Future of the North American Medical Carts Industry

A lucrative opportunity for such prominent medical device manufacturers towards consolidating their presence in the medical carts market in North America is changing their product line following a shift in technology. Mechanical medical carts are being gradually replaced by new and enhanced technologies such as powered medical devices with battery systems, locking drawers (with a negative tilt to facilitate efficient stocking of medication), and automated medicine dispensing systems.

In addition to this, increased focus on acquisitions and collaboration among companies has helped them expand their clinical carts product portfolio and cater to the demand for efficient healthcare systems. This has boosted the need for more effective and advanced medical equipment, devices and procedures. Emerging players must keep in mind that acquisitions over the years have resulted in strengthening the positions of current market leaders.

Key Highlights of the Report follow,

In 2017 and beyond, computer medical carts will remain in great demand, procuring close to 40% of the market’s overall revenues towards the end of 2027
North America’s medical carts market is poised to witness the dominance of metal as base material, revenues from which will reflect a CAGR of 12.1%
Non-powered medical carts will also be top-sellers in the market, while revenues from sales of powered medical carts are anticipated to showcase a 12.6% CAGR
Hospitals will be the largest end-users of medical carts in North America

Ask An Analyst
https://www.futuremarketinsights.com/ask-question/rep-na-3608

Key Segments:

By End User:

Hospitals
Clinics
Ambulatory Surgical Centres
Diagnostic Centres
Others

By Region:

North America
Latin America
Western Europe
Eastern Europe
APEJ
Japan
MEA

By Material Type:

Metal
Plastic
Wood

By Energy Source:

Powered
Non-Powered (Mechanical)

By Product Type:

Emergency Carts
Procedure/Treatment Carts
Anaesthesia Carts
Medical Computer Carts
Others

Buy the Full Report Now:
https://www.futuremarketinsights.com/checkout/3608

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Global Varicose Vein Treatment Industry is predicted to reach a value of US$ 1.4 Billion with a compound annual growth rate of 6.8% By 2033 | FMI

The Global Varicose Vein Treatment Industry is on track for a period of significant expansion, according to a recent study by Future Market Insights (FMI). The market, valued at US$765.2 million in 2023, is projected to reach a staggering US$1.477.3 million by 2033, reflecting a robust Compound Annual Growth Rate (CAGR) of 6.8% over the forecast period.

The demand for varicose vein treatments is expected to fuel this remarkable growth, driven by the effectiveness of treatments, the adoption of user-friendly devices, and the increasing emphasis of medical practitioners on ensuring patient safety during critical varicose vein procedures. By the end of 2026, the global market for varicose vein treatment is projected to reach a value of US$ 931.4 million, showcasing a robust growth rate at 6.4% CAGR.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-2538

Unattended varicose veins can cause severe pain through swelling, ulceration, venous eczema, and lipodermatosclerosis. Treating them through appropriate measures becomes quite crucial. One may opt for non-surgical remedies such as sclerotherapy, leg elevation, or alternative invasive techniques such as endovenous laser treatments. Collectively, these therapies can be addressed as varicose vein treatments, medically practised in all parts of the world. The demand for such varicose vein treatments is expected to grow in the years to come.

Global Varicose Vein Treatment Industry Opportunities

Backed with strong clinical evidence, endovenous laser ablation devices are more popular to treat varicose veins. However, compared to other procedures such as foam fillers, vein stripping costs, and blast with electricity, endoscopic variceal ligation (EVL) is a costlier treatment alternative. The launch of cost-effective EVL devices will work as a favourable opportunity for new entrants as well as existing players in the market. Decreasing the procedure costs and enhancing the adoption of affordable devices will cumulatively boost the adoption of varicose vein treatments.

Among the wide variety of endovenous laser ablation devices available in the market, some of them may lead to complications such as thrombophlebitis, nerve damage, burns and deep vein thrombosis conditions. There is a potential opportunity for endovenous laser ablation device manufacturers to tap the larger market by offering competitive products that cause fewer complications.

Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-2538

APEJ Varicose Vein Treatment Market to Record Speedy Growth

Apropos the report, more than 40% of the market revenues will remain concentrated in North America, throughout the forecast period. By 2026-end, North America’s varicose vein treatment market will have reached a value of US$ 420 Mn. US-based AngioDynamics, Inc. will be observed as a key player in the market during this period. In terms of revenue growth, the varicose vein treatment market in Asia-Pacific excluding Japan (APEJ) region is projected to be at the forefront.

By exhibiting 7% CAGR, the APEJ varicose vein treatment market will witness the active participation of Korean medical device manufacturer, Wontech Co., Ltd. Apart from these, Syneron Medical Ltd., Dornier MedTech GmbH, Alma Lasers Ltd., Alna-Medicalsystem GmbH, LSO Medical, Energist Ltd. and intros Medical Laser GmbH are other companies partaking in the growth of Global Varicose Vein Treatment Industry.

The report further reveals that hospitals and ambulatory surgical centres as end-users will account for a larger share of global revenues, while specialised clinics will register the fastest revenue growth at 7.2% CAGR. The report also identifies endovenous laser treatment as the dominant Global Varicose Vein Treatment Industry, procuring revenues worth over US$ 500 Mn by the end of 2026.

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/2538

Global Varicose Vein Treatment Industry Taxonomy By End User

Hospitals
Ambulatory Surgical Centres
Specialised Clinics

By Treatment Type

Endovenous Laser Systems
- Diode Lasers
- Yag Lasers
Endovenous Laser Fibres
- Bare Tip Laser Fibres
- Radial Tip Laser Fibres
- Gold Tip Laser Fibres
Treatment
- Non-thermal Ablation
- Radiofrequency Ablation
- Sclerotherapy

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Global Smart Insulin Pens Industry is predicted to grow at an 8.3% annual rate and reach US$ 8,750.7 Million by 2033 | FMI

The Global Smart Insulin Pens Industry is on the precipice of a significant transformation, driven by a growing diabetic population and the need for innovative diabetes management solutions. According to a recent industry report, the market is projected to experience a remarkable surge, reaching an impressive US$8,750.7 million by 2033, reflecting a robust Compound Annual Growth Rate (CAGR) of 8.3%.

This phenomenal growth signifies the increasing adoption of smart insulin pens, which are revolutionizing diabetes management. These innovative devices offer a plethora of advantages over traditional insulin pens

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-1827

Manufacturers are thus capitalizing on these trends to launch fresh and inventive product lines, allowing them to gain a firm foothold in the market. Medtronic, for example, will debut its InPenTM smart insulin device with real-time GuardianTM Connect CGM Data in November 2020, making it the first smart insulin pen for diabetics who require many daily injections. BioCorp and Roche Diabetes Care just launched the Mallya smart insulin pen device in France in April 2021.

Key Takeaways from FMI’s Global Smart Insulin Pens Industry Report

Bluetooth-enabled Smart Insulin Pens will account for more than half of the revenue share by 2031.
According to indications, type 2 diabetes therapy will account for the majority of smart insulin pen deployment.
Smart Insulin Pens were primarily distributed through retail pharmacies, with e-commerce sales fast increasing.
The United States will see credible growth as the approval rate for new diabetes treatment devices rises.
Growing acceptance of needle-free insulin injections in the United Kingdom
In the long run, Germany and France will see increasing collaboration between key manufacturers.
A high concentration of regional manufacturers will drive growth in India and China.

Grab Your Discount Now Before It Is Gone!
https://www.futuremarketinsights.com/request-discount/rep-gb-1827

Global Smart Insulin Pens Industry – Key questions answered in the report

What trends are in store for the Global Smart Insulin Pens Industry growth?

According to FMI, the Global Smart Insulin Pens Industry is expected to reach multi-billion dollar valuations in both the short and long run, owing to an increase in the global diabetes population pool and the resulting increase in hospital workload. Bluetooth-enabled Smart Insulin Pens are predicted to stay in high demand.

Which is the most promising Global Smart Insulin Pens Industry?

According to FMI’s estimate, demand for Smart Insulin Pens is projected to continue high in the US market, owing to the government’s ongoing efforts to eradicate the diabetes epidemic through major advertising campaigns. Furthermore, with the presence of multiple regional-level producers, India and China are likely to emerge as the main markets in the Asia-Pacific region.

Global Smart Insulin Pens Industry Competitive Landscape

significant insulin pen manufacturers are efficiently using significant expansion tactics, such as new product releases and R&D, collaboration with current manufacturers, and outright/partial purchase of important market participants. The incorporation of virtual technological breakthroughs to improve diabetes care is being prioritized.

Novo Nordisk and the University of Toronto signed a CAD 40 million investment agreement in February 2021 to establish the Novo Nordisk Network for Healthy Populations. This network will concentrate on novel methods of diabetes management and chronic disease prevention. This will most likely aid in the creation of Smart Insulin Pens.

Get Your Customized Impactful Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-1827

Companies are also focusing on providing advanced software platforms, such as Digital Medics’ DiabetesPlus DataSync Software. This platform enables users to download insulin and glucose data directly from the device. Key features include downloading insulin data from the insulin pen, glucose levels from the glucose meter, and synchronization of data on the Cloud for use with mobile devices.

Global Smart Insulin Pens Industry Key Players

Digital Medics Pty Ltd.
Emperra GmbH e-Health Technologies
Companion Medical Inc.
Sanofi Aventis LLC
Novo Nordisk A/S
Eli Lily and Company
Companion Medical
Diabnext
Jiangsu Delfu Medical Device Co. Ltd.
DIAMESCO Co Ltd.
Patients Pending Ltd (Bigfoot Biomedical Inc.)
BERLIN-CHEMIE

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/1827

Global Smart Insulin Pens Industry – Key Segments Covered

Indication

Diabetes Type I
Diabetes Type II

Connectivity

Bluetooth Connected
USB Connected

Distribution Channel

Clinics & Ambulatory Surgical Centers
E-Commerce
Retail Pharmacies

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Global Dengue Vaccines Industry is poised to soar, surpassing US$ 1.6 Billion by 2033 with a strong double-digit CAGR | FMI Reports

The Global Dengue Vaccines Industry is on the cusp of a significant expansion, driven by a rising need for effective solutions against this debilitating mosquito-borne disease. According to a new report by Future Market Insights (FMI), a leading market research firm, the market is projected to surpass a staggering US$ 1.6 billion by 2033, reflecting a robust double-digit Compound Annual Growth Rate (CAGR).

Key pharmaceutical companies, having successfully concluded clinical trials, are gearing up for potential new product launches. Analysts express optimism about the imminent expansion of the growth horizon within the Dengue vaccine industry. The strategic insights provided by FMI underscore the industry’s potential to address the rising prevalence of dengue fever, particularly in the Asia-Pacific region.

The Asia-Pacific region has witnessed a surge in the incidence of dengue fever, escalating the demand for effective medicines and vaccines to combat this viral disease. Against this backdrop, some pharmaceutical companies are focusing on the development of innovative dengue vaccines. FMI’s latest report highlights a positive trajectory for the Global Dengue Vaccines Industry, with a projected total valuation of US$ 474.8 million expected in 2023.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-1763

Geographic Overview

Latin America is expected to remain the second largest market for dengue vaccines, with a valuation of nearly US$ 290 million by the end of the forecast period. The report also predicts that more pharmaceutical companies will become involved in the expansion of the Global Dengue vaccine industry shortly.

According to the report, government institutes will continue to be the largest end-users of dengue vaccines. Dengue vaccine sales across government institutes will generate nearly US$650 million in revenue by the end of 2027. Furthermore, hospitals will maintain their dominance, with double-digit CAGRs throughout the forecast period. Sales of the sole vaccine, Dengvaxia, manufactured by Sanofi, are currently driving market growth. Furthermore, the factors influencing the market growth profiled in the report are discussed below.

Key Highlights of Global Dengue Vaccines Industry Report

Other than the burdening occurrence of dengue in some countries, the economic turmoil in Latin America is estimated to influence the growth of the global market at the macroeconomic level.
Live attenuated vaccines are also produced and developed economically, thereby consoling the vaccine market and patients.
Low availability of optimum diagnostic systems and lack of skilled professionals have led to cases, where dengue fever is being treated as undistinguished febrile disease.
The global market of dengue vaccines is likely to secure an opportunistic revolution when companies are likely to able to successfully develop effective vaccines for all age groups.

Overall, the global dengue vaccines market, which is currently valued at nearly US$ 250 million, will increase rapidly to reach over US$ 1,250 million in terms of revenues, by the end of 2027.

Discovering the assumptions behind the study. Talk to Analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-1763

According to FMI’s report, the following dengue vaccine manufacturers operate within the Global Dengue Vaccines Industry landscape:

Sanofi Pasteur Limited
Takeda Pharmaceutical Company Limited
Merck & Co. Inc.
GlaxoSmithKline Plc.
GeneOne Life Science Inc.
Medigen Vaccine Biologics Corporation
Panacea Biotec Limited
Sun Pharmaceutical Industries Ltd
Serum Institute of India Pvt. Ltd.
Biological E Ltd.

Global Dengue Vaccines Industry Key Segments Covered

Product

CYD-TDV (Dengvaxia)

End-User

Hospitals
Government Institutes
Non-governmental Organizations (NGOs)

Region

North America (US and Canada)
Latin America (Brazil, Mexico, Venezuela and Rest of LATAM)
Western Europe (Germany, UK, France, Spain, Italy and Rest of Western Europe)
Eastern Europe (Russia, Poland and Rest of Eastern Europe)
APEJ (The Philippines, Indonesia, Malaysia, Thailand, Vietnam, India and Rest of APEJ)
Japan
Middle East & Africa (GCC, Northern Africa, South Africa and Rest of MEA)

Click Here To Buy Your Detailed Report
https://www.futuremarketinsights.com/checkout/1763

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Global Cold Cough And Sore Throat Remedies Industry is expected to reach a valuation of US$37.7 Billion by 2032 | FMI

The Global Cold Cough And Sore Throat Remedies Industry is projected to maintain a steady growth trajectory, reaching a valuation of US$37.7 billion by 2032, according to a recent industry report. This represents a Compound Annual Growth Rate (CAGR) of 0.6% from 2022.

The market’s upward trajectory is propelled by factors such as the increasing prevalence of infectious diseases, a rising awareness of health matters among the population, and the escalating consumption of various medications, including antihistamines, antibiotics, and bronchodilators. These dynamics collectively contribute to the positive momentum in the global cold, cough, and sore throat remedies market.

Seeking professional medical help for curing a cold, cough, or sore throat becomes a rare practice, let alone getting admitted in a hospital. The prevalence of cold, cough & sore throat problems through the ages has made people more independent in terms of treating them. In the years to come, effective home remedies will continue to gain traction and people will be taking care of their cold or sore throat through such easy-to-treat remedies.

Get the Sample Copy of this Report!
https://www.futuremarketinsights.com/reports/sample/rep-gb-1292

In the report, titled “Cold, Cough and Sore Throat Remedies Market: Global Industry Analysis and Opportunity Assessment, 2016-2026,” affordability of OTC drugs, the rising economic burden of respiratory diseases, the availability of medications in variable dosages, and fast & instant relief delivered through such cold, cough & sore throat remedies are driving the market’s growth. Nevertheless, the demand for cold, cough & sore throat remedies is less likely to soar at a healthy rate.

Product Recalls & Low Entry of New Players Impacting the Market’s Growth

Firstly, the global cold, cough & sore throat remedies market is projected to witness umpteen product recalls. Global leaders in pharmaceuticals industry such as Novartis AG, Pfizer Inc., Bayer AG, GlaxoSmithKline plc., and Reckitt Benckiser Group plc are key players in the global market for cold, cough & sore throat remedies. Despite, several newly-launched products have been recalled after FDA’s censure. Besides, even consumer goods behemoths such as Procter & Gamble Co. and Johnson & Johnson Services Inc. are partaking in the market’s growth. This has resulted in a lowering entry of emerging drugmakers, which has further distorted the market’s growth. Other leading manufacturers of cold, cough & sore throat remedies include AstraZeneca plc, Prestige Brands Inc., and Sun Pharmaceutical Industries Ltd.

The report highlights how Asia-Pacific Excluding Japan (APEJ) region will remain the largest market for cold, cough & sore throat remedies. The region’s proximity to environmental pollution makes its residents more prone to respiratory diseases. With over 30% stake in global revenues, the APEJ cold, cough & sore throat remedies market will global dominate through 2026. North America and Europe will also remain at the forefront, by collectively accounting for nearly half of the global revenues throughout the forecast period.

Ask from Market Research Expert
https://www.futuremarketinsights.com/ask-question/rep-gb-1292

The report further reveals that in 2017 and beyond, the demand for antihistamine drugs, expectorants and decongestants will remain considerably high as the revenues from sales of these drugs will showcase growth at more than 3% CAGR. Tablets or pills and nasal drops will also dominate as dosage types, accounting for over 40% share of market value through 2026. The report also predicts retail pharmacies & drug stores as the largest distribution channels for cold, cough & sore throat remedies. Together, these channels will bring in nearly US$ 30 Bn by the end of 2026.

Key segments covered in this report

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Supermarket/ Hypermarkets
e-Commerce/ Online pharmacies

By Dosage Type

Oral Syrup
Tablets/Pills
Lozenges
Nasal Drops
Others

By Drug Type

Antihistamines
Expectorants
Bronchodilators
Decongestants
Antibiotics
Others

Click Here To Buy Your Detailed Report
https://www.futuremarketinsights.com/checkout/1292

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Global Food Color Market Forecasts a Moderate Advancement at a CAGR of 5.80% to reach the Market Valuation of US$ 8.46 billion- FMI Report

The market valuation of the global food color market was US$ 4.76 billion in 2023. This market valuation is estimated to reach US$ 4.83 billion in 2024. In addition, the moderate CAGR of 5.80% shall elevate the market valuation to US$ 8.46 billion by 2034. This market development is influenced by various critical market forces that help the market grow.

Consumers have started to become more aware of their physical health, which raises concerns regarding healthy food and diet. Due to this, consumers have been demanding natural additives. This surges the demand for natural colors in food, which acts as one of the key market drivers.

Request the Sample Copy today! https://www.futuremarketinsights.com/reports/sample/rep-gb-14818

Due to intercultural exchange, various global cuisines have crossed borders to reach different parts of the world. This emphasizes the demand for colors to give a conventional appearance to the cuisine, which is another market driver for the subject market.

Food appearance has gained significant importance. Due to this, cuisine preparation needs to be attractive. Consequently, to enhance the look of a dish, the use of colors has become common, which surges the demand for colors. As a result, this creates another crucial market driver for the said market.

Marketing channels have gained rising importance, emphasizing the look of a dish or beverage. Due to this, the rise of media marketing channels surges the demand for food additives. Thus, the changed marketing landscape is playing a role as the market driver.

Key Takeaways from the Market Study

The market’s CAGR from 2019 to 2023 was 5.3%, which rose to 5.8% from 2024 to 2034. This is an optimistic scenario for the subject market.
Food manufacturers use vibrant colors more to attract consumers. However, excessive additives might affect human health, which is one of the key hindrances for the market.
The United States of America leads North America. It forecasts progress at a moderate CAGR of 5.5%.
Germany leads the European market, wherein the rising population has been one of the key factors for the market progress. It estimates the market advancement at a CAGR of 5.5%.

“The increased consumption of bakery items has surged the demand for food additives, particularly synthetic colors, to increase their shelf life and appearance. This has been driving the market segment significantly, contributing to its growth,” claims the FMI analyst.

Request Methodology for a Comprehensive Analysis! https://www.futuremarketinsights.com/request-report-methodology/rep-gb-14818

Competitive Landscape

The discrete distribution of competitors globally creates several opportunities for new entrants. However, the global canvas creates various challenges for the players, as different countries have different laws and regulations for food additives.

Competitors bolster their market presence through various market strategies, including strategic alliances, partnerships, mergers and acquisitions, product development, and many other key strategic initiatives. These moves help marketers gain a competitive advantage.

In April 2019, Archer Daniels Midland Company innovated micronized color powder and added it to the organization’s existing product line.
In December 2021, Givaudan acquired DDW, which helped the business to penetrate the global market. The distribution network could be bolstered through this initiative.
In June 2022, Sensient Technologies Corp. acquired Endemix Doal Maddeler AS, which developed the business’s working market verticals.

The following organizations actively participate in the market competition:

Archer Daniels Midland Company
Allied Biotech Corporation
DIC Corporation (BASF SE)
BioconColors
DDW, The Color House
Döhler Group
GNT International B.V.
Kalsec Inc.
DSM
Naturex S.A.
ROHA ( A JJT Group Company)
San-Ei Gen F.F.I., Inc.
Sensient Colors LLC.
Symrise AG
Chr. Hansen Holding A/S

More Valuable Insights Available

Future Market Insights offers an unbiased global food color market analysis, providing historical data from 2019 to 2023 and forecast statistics from 2024 to 2034.

The food color market is segmented based on color type (natural and synthetic), end-use application (beverage, bakery, snacks and cereal, dairy, fruit preparations/fillings, meat, poultry, fish and eggs, sauces, soups and dressings, seasonings, and pet food) and form (liquid, powder and gel) across seven major countries (North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, and the Middle East and Africa).

Buy Report Now! https://www.futuremarketinsights.com/checkout/14818

Food Color Market – Key Segments

By Color Type:

Natural
- Beta Carotene
- Carmine
- Black Carrot Concentrated Juice
- Grape Skin Red/Anthocyanidin
- Lutein
- Turmeric
- Red Beet
- Malt Extract
- Spirulina
Synthetic Food Colors

By End-use Application:

Beverage
- Milk Drinks and Milk Alternatives
- Alcoholic Beverages
- Carbonates (Carbonated Soft Drinks)
- Sports Drinks
- Coffee and Cocoa
- Tea
- Energy Drink
Bakery, Snacks and Cereal
- Breakfast Cereal
- Bread
- Cakes and Pastries
- Cookies
- Biscuits and Cones
Dairy
Fruit Preparations/Fillings
Meat, Poultry, Fish and Eggs
Sauces, Soups and Dressings
Seasonings
Pet Food

By Form:

Liquid
Powder
Gel

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
The Middle East and Africa

About the Food and Beverages Team at Future Market Insights

Future Market Insights food and beverage team offers expert analysis, time-efficient research, and strategic recommendations to provide authentic insights and accurate results to help clients worldwide. With over 100+ reports and one million+ data points, the team has lucidly analyzed the industry in 50+ countries for over a decade. The team briefly analyzes key trends, including competitive landscape, profit margin, and research development efforts.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube